The Chinese Losartan Potassium market registered a steady upward pricing trend throughout March xxxx, supported by tightening domestic supply, accelerated international demand, and rising production costs. As a key active pharmaceutical ingredient (API) widely used in antihypertensive therapies, Losartan Potassium remains a critical export product for China, with international buyers closely monitoring supply and pricing developments.
-
Losartan Potassium prices in China rose by x.xxx in March xxxx due to export-driven demand, trade uncertainty, and rising production costs.
-
U.S. tariff hikes on Chinese pharmaceutical exports triggered frontloaded international procurement, tightening supply for Losartan Potassium.
-
Rising operational costs and increased industrial activity drove up input costs and pressured producer margins.
-
Domestic demand remained stable, while reduced freight rates supported stronger export competitiveness for Losartan Potassium.
-
Market sentiment for April remains bullish amid persistent supply constraints and elevated production expenses.
According to 果酱视频, Losartan Potassium (USP) FOB Zhejiang prices rose by x.xxx in March xxxx,...
